{{Rsnum
|rsid=1048201
|Gene=NUDT6
|Chromosome=4
|position=122893153
|Orientation=plus
|GMAF=0.2167
|Gene_s=FGF2,NUDT6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 62.5 | 32.1 | 5.4
| HCB | 34.8 | 49.6 | 15.6
| JPT | 31.2 | 47.3 | 21.4
| YRI | 94.4 | 4.9 | 0.7
| ASW | 98.2 | 1.8 | 0.0
| CHB | 34.8 | 49.6 | 15.6
| CHD | 34.3 | 44.4 | 21.3
| GIH | 37.6 | 48.5 | 13.9
| LWK | 90.9 | 9.1 | 0.0
| MEX | 78.6 | 21.4 | 0.0
| MKK | 87.2 | 12.8 | 0.0
| TSI | 72.3 | 25.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19586755
|Title=Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
}}

{{PMID Auto
|PMID=20641033
|Title=Polymorphisms in predicted miRNA binding sites and osteoporosis
|OA=1
}}

{{PMID Auto
|PMID=17204151
|Title=VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis.
|OA=1
}}

{{GET Evidence
|gene=NUDT6
|aa_change=Arg40Gln
|aa_change_short=R40Q
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1048201
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}